Jun 2026 (Q2 FY26) — Aug 12, 2026
Lumexa Imaging Holdings, Inc. Q2 FY26 — Record Advanced Modality Volume and Strong Cash Flow
Read the full callLumexa Imaging Holdings (LMRI) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
Lumexa Imaging Holdings earnings: last reported Wed, 12 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 264 | +5.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 8.7 | −2.3 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 2.7 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$10.72 −0.56% · −$0.06
Performance −42.1% YTD
YTD: $18.5 on 31 Dec 2025 → $10.72. High $18.5 (31 Dec 2025), low $6.77 (18 May 2026).
- Previous close
- $10.78
- 52-week range
- $6.77 – $18.53
Overview
- Symbol
- LMRI
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Lumexa Imaging Holdings earnings calls (LMRI)
Financials
What the filings say
Net profit, year on year: +138% (quarter to jun 2026 against jun 2025).
| Line item | Mar 2025 | Jun 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Sales | 245 | 251 | 253 | 264 |
| Operating profit | 26 | 28 | 19 | 23 |
| Operating margin | 10.4% | 11.0% | 7.7% | 8.7% |
| Interest | 30 | 30 | 16 | 16 |
| Profit before tax | -4 | -2 | 3 | 6 |
| Tax rate | −78.4% | −199.0% | 44.3% | 52.4% |
| Net profit | -8 | -7 | 2 | 3 |
| EPS ($ per share) | -0.11 | -0.10 | 0.02 | 0.03 |
Insider filings
21 filings between Dec 12, 2025 and Jun 10, 2026.
Open market
decisions to buy or sellPurchases
$476.9K
2 purchases by 2 insiders
Sales
None
No insider sold shares.
Compensation
not trading decisions- 18
- Award — granted as compensation
- 1
- Option exercise — converted options into shares
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| BRODNAX BRETT | $253.8K | — | May 19, 2026 |
| Cooper Henry Lee | $223.1K | — | May 14, 2026 |
Latest filings (21)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Jun 10, 2026 | BRODNAX BRETT Director | Award | 19,358 | $0 |
| Jun 10, 2026 | Cooper Henry Lee Director | Award | 19,358 | $0 |
| Jun 10, 2026 | EISENBERG GLENN A Director | Award | 19,358 | $0 |
| Jun 10, 2026 | Joseph Molly Director | Award | 19,358 | $0 |
| Jun 10, 2026 | Karlin Bridget E Director | Award | 19,358 | $0 |
| Jun 10, 2026 | Lungren Matthew Director | Award | 19,358 | $0 |
| Jun 10, 2026 | Mittl Robert Louis Jr. Director | Award | 19,358 | $0 |
| May 19, 2026 | BRODNAX BRETT Director | Purchase | 35,000 | $253.8K |
| May 14, 2026 | Cooper Henry Lee Director | Purchase | 30,000 | $223.1K |
| Feb 25, 2026 | Walker James Edward Jr. Principal Accounting Officer | Award | 12,414 | $0 |
| Dec 12, 2025 | Martin James Anthony Chief Financial Officer | Award | 27,027 | $0 |
| Dec 12, 2025 | Martin James Anthony Chief Financial Officer | Award | 27,027 | $0 |
| Dec 12, 2025 | Walker James Edward Jr. Principal Accounting Officer | Award | 4,932 | $0 |
| Dec 12, 2025 | Szeker Julie Chief Legal Officer & Corp Sec | Option exercise | 66,182 | — |
| Dec 12, 2025 | Szeker Julie Chief Legal Officer & Corp Sec | Award | 81,081 | $0 |
| Dec 12, 2025 | Stewart Russell Chief Medical Officer | Award | 4,232 | $0 |
| Dec 12, 2025 | Stewart Russell Chief Medical Officer | Award | 4,232 | $0 |
| Dec 12, 2025 | Joseph Molly Director | Award | 27,027 | $0 |
| Dec 12, 2025 | BRODNAX BRETT Director | Award | 27,027 | $0 |
| Dec 12, 2025 | Zulla Caitlin Chief Executive Officer | Award | 64,864 | $0 |
| Dec 12, 2025 | Zulla Caitlin Chief Executive Officer | Award | 64,864 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Lumexa Imaging Holdings, Inc.
Free account. Everything above stays public.
Write why you follow Lumexa Imaging Holdings, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading